Cargando…
Cardioprotective cytokine interleukin‐33 is up‐regulated by statins in human cardiac tissue
Interleukin (IL)‐33 is a member of the IL‐1 family and is able to act cardioprotective. The aim of this study was to investigate the regulation of IL‐33 by 3‐hydroxy‐3‐methylglutaryl‐coenzyme‐A (HMG‐CoA) reductase inhibitors (statins) and bisphosphonates (BPs) in human cardiac tissue. The lipophilic...
Autores principales: | Pentz, Richard, Kaun, Christoph, Thaler, Barbara, Stojkovic, Stefan, Lenz, Max, Krychtiuk, Konstantin A., Zuckermann, Andreas, Huber, Kurt, Wojta, Johann, Hohensinner, Philipp J., Demyanets, Svitlana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237563/ https://www.ncbi.nlm.nih.gov/pubmed/30216659 http://dx.doi.org/10.1111/jcmm.13891 |
Ejemplares similares
-
Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature
por: Demyanets, Svitlana, et al.
Publicado: (2013) -
The Paradigm Change of IL-33 in Vascular Biology
por: Demyanets, Svitlana, et al.
Publicado: (2021) -
Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation
por: Stojkovic, Stefan, et al.
Publicado: (2016) -
Urokinase plasminogen activator protects cardiac myocytes from oxidative damage and apoptosis via hOGG1 induction
por: Hohensinner, Philipp J., et al.
Publicado: (2017) -
Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome
por: Demyanets, Svitlana, et al.
Publicado: (2014)